International Lymphoedema Framework
- Active
- Small
- 17 years
- 1m-15m
- Virtual address
- 3 directors
- No owners
- London
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Summary
International Lymphoedema Framework is a private limited company by guarantee without share capital, use of 'limited' exemption registered in England/Wales with the registration number 06792587. The company was founded seventeen years ago on January 15, 2009, and registered at W5 3RA, London, 7-8 Ritz Parade, Western Avenue. The address is probably virtual as fifty five companies are registered at the same address. Its status is active. The company operates in the professional services, the education, the undergraduate, the scientific and technical r&d industries. Officially, it has not published owners as their shares less than twenty five percent for each shareholder. It has three directors and no number of employees published.
It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Managers
-
Individual
- 8 years
-
Resident of Canada
-
Individual
- 14 years
-
Resident of Denmark
-
Individual
- 17 years
- 1
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted four months ago.
Last news
-
Confirmation statement made on 2026-01-15 with no updatesDownload 3 pages pdf report
-
Total exemption full accounts made up to 2024-12-29Download 15 pages pdf report
-
Previous accounting period shortened from 2024-12-30 to 2024-12-29Download 1 page pdf report
FAQ about International Lymphoedema Framework
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.